Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.

Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?

Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...

Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...

Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on raised 2025 guidance and second-quarter results that beat the ...

Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G's indications, including for type 2 ...

Boston Scientific won FDA approval for Agent last year, making it the first drug-coated coronary balloon available in the U.S. The company also offers it commercially in several international markets, ...

This notice comes just weeks after an initial warning about potential underinfusion with all Novum IQ large-volume pumps.

Dexcom (Nadsaq:DXCM) announced today that Jake Leach will succeed Kevin Sayer as CEO, effective Jan. 1, 2026.